ClinicalTrials.gg
Not yet recruitingNCT07051148Updated May 27, 2026

Efficacy of a Personalized, Response-based Transdiagnostic Intervention for Emotional Disorders Delivered Via the Internet: A Protocol for an Adaptive Randomized Controlled Trial

An interventional study of UJI Online Transdiagnostic Protocol and UJI On Line Transdiagnostic Hibrid Protocol in Emotional Disorders, Anxiety and Depression, Unipolar, sponsored by Universitat Jaume I. Not yet recruiting. Open to participants aged 18 Years to 70 Years. Per ClinicalTrials.gov, last updated 2026-05-27.

Primary conditionDepressive DisorderRegistry: Anxiety DisordersReclassifiedWhy we changed it
Registry
Anxiety Disorders — the first condition term the registry derived for this study.
ClinicalTrials.gg
Depressive Disorder
Why
  1. The registry often attaches Anxiety Disorders to studies about something else, and this study's title and listed conditions do not name it.
  2. The study's listed conditions name Depressive Disorder.
Confidence
High: the new condition is named in the study's own listed conditions. Of 351 hand-checked studies reclassified this way, 68% were exactly right and 84% in the right disease family; the registry's first term was right for 5% (measured 2026-10-21). How we classify →
Wrong?
Tell us the study's main condition →

Sponsored by Universitat Jaume I · Not applicable, Interventional, and Treatment

How we know

Help build ClinicalTrials.gg — short surveys, remote interviews or testing, in your language. Take part →

Phase
Not applicable
Study type
Interventional
Enrollment
366
Allocation
Randomized
Ages
18 Years to 70 Years
Sex
All
01

Study summary

This adaptive randomized controlled trial evaluates the efficacy of a transdiagnostic, internet-delivered psychological intervention for emotional disorders, tailored to patient´s early clinical response. 366 adults with clinically significant symptoms of depression and/or anxiety will begin a 12 module self-applied program. Based on sympton reduction after the first three modules, participants will be classified as early or late responders and randomized into different experimental arms. The main hypothesis is that a hybrid format (self-applied modules plus synchronous sessions with a therapist) will yield better outcomes for late responders. Outcomes include symptom reduction, emotional regulation and internet based therapheutic alliance.

Read the detailed description

To assess its effectiveness, two formats will be compared: the original, consisting of 12 self-administered modules, and a hybrid format, which includes two synchronous videoconference sessions with a trained therapist. Early responders will either continue with the original intervention or discontinue treatment; while late responders will receive the hybrid format or continue with the original intervention. The primary expected result is that the hybrid format will improve treatment outcomes for late responders compared to the self-applied format. The findings are expected to inform clinical practice by highlighting the importance of assessing symptomatic response throughout treatment, especially in its early phases.

02

Conditions studied

  • Emotional Disorders
  • Anxiety
  • Depression, Unipolar

Browse trials for

Keywords

  • transdiagnostic
  • internet based therapy
  • anxiety
  • depression
  • Emotional Disorders
  • adaptive intervention
  • blended treatment
  • digital interventions
  • personalization
  • personalized treatment
  • adaptive trial
03

In context

Depressive Disorder Reclassified

857 studies on the registry are indexed under Depressive Disorder; 160 are open to participants now.

This study's planned enrollment of 366 is above the median of 87 across 691 interventional studies indexed under Depressive Disorder.

Browse Depressive Disorder studies →

Lead sponsor

Universitat Jaume I is the lead sponsor of 80 studies on the registry; 19 are open to participants now.

Compared within Depressive Disorder, this study's primary condition as ClinicalTrials.gg classifies it; the registry's first condition term is Anxiety Disorders. The counts are of registry records indexed under each term, refreshed daily. How we classify →

04

Who can participate

Ages eligible
18 Years to 70 Years
Sexes eligible
All
Accepts healthy volunteers
No

Go through the criteria one by one — yes, no or not sure — and take the list to your doctor or the study team. Kept in this browser only.

Inclusion criteria

  • Spanish speakers
  • OASIS score +/= 8
  • ODSIS score +/= 7
  • Access to Internet
  • Email

Exclusion criteria

Exclusion Criteria:

  • Severe mental disorder: schizophrenia/bipolar disorder
  • Active substance abuse
  • High suicide risk
  • Ongoing psychological/pharmacological treatment
  • Interfering physical illness
05

Study design

Phase
Not applicable
Primary purpose
Treatment
Allocation
Randomized
Intervention model
Parallel assignment
Masking
Single (Participant)
Enrollment
366 participants (estimated)

Study arms

  • Experimental
    Early responders selfapplied completed

    Behavioral: UJI Online Transdiagnostic Protocol

  • Experimental
    Early responders selfapplied interrupted

    Behavioral: UJI Online Transdiagnostic Protocol

  • Experimental
    Late responders selfapplied

    Behavioral: UJI Online Transdiagnostic Protocol

  • Experimental
    Late responders blended

    Behavioral: UJI On Line Transdiagnostic Hibrid Protocol

Interventions

  • BehavioralUJI Online Transdiagnostic Protocol

    Is a manualized treatment for emotional disorders delivered through an interactive multimedia platform. The self applied format consists of 12 self applied modules (psychoeducation, emotional processing, cognitive flexibility training, exposure, coping strategies, maladaptive behaviors, avoidance, etc)

  • BehavioralUJI On Line Transdiagnostic Hibrid Protocol

    Hybrid format: 12 self applied modules with two synchronous videoconference sessions with a trained therapist

06

What researchers measure

Primary outcomes

  1. Clinical Outcomes in Routine Evaluation (CORE-34, Evans et al., 2002)

    Is a self report questionnaire designed to assess psychological distress and global functioning across four domains: subjective well being, problems/symptoms, functioning and risk. Items are rated on a 5 point Likert scale. The instrument has demostrated good psychometrics properties. Higher scores indicate greater psychological distress.

    Time frame: Day 1 (BL) Week 3, 6, 9, 12 Week 25 Year 1

  2. Clinical Outcomes in Routine Evaluation 10 (CORE 10, Barkham et al., 2013)

    Is a Self-report 10-items questionnaire with 5 Likert response options. Assess general distress. Validated for Spanish speaking population with adequate internal consistency, convergent validity and sensitivity to change.

    Time frame: Day 1 (BL) Week 1, 2, 4, 5, 7, 8, 10, 11

Secondary outcomes

  1. Difficulties in Emotion Regulation Scale (DERS, Gratz & Roemer, 2004)

    Self- report 28-items questionnaire with 5 Likert response options. The scale assesses emotion regulation process and several difficulties associated. Adapted and validated in Spain with sound psychometric properties reported -internal consistency, test-retest reliability, convergent and incremental validity.

    Time frame: Day 1 (BL) Week 3, 6, 9, 12 Week 25 Year 1

  2. Inventory of Interpersonal Problems (IIP32, Horowitz, 2000)

    Is is a self-report questionnaire designed to assess interpersonal difficulties experienced over the past month. It covers eight dimensions of interpersonal functioning (e.g., being too controlling, socially inhibited, or self-sacrificing). Each item is rated on a 5-point Likert scale. The IIP-32 is a widely validated and efficient tool for identifying interpersonal patterns relevant to psychological distress and treatment planning.

    Time frame: Day 1 (BL) Week 3, 6, 9, 12 Week 25 Year 1

  3. Overall Anxiety Severity and Impairment Scale (OASIS; Norman et al., 2006)

    Self-report 5-item questionnaire that assesses frequency and severity of anxiety symptoms during the previous week. With 5 Likert response options (from 0 to 4). Adapted in Spain with good internal consistency (α = .86) and test-retest reliability (k= .84)

    Time frame: Day 1 (BL) Week 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12 Week 25 Year 1

  4. Overall Depression Severity and Impairment Scale (ODSIS; Bentley et al., 2014)

    Self-report 5-item questionnaire with 5 Likert response options (from 0 to 4). Assesses frequency and severity of depression symptoms during the previous week. Adapted in Spain with excellent psychometrics properties, internal consistency (α = .93) and convergent and discriminant validity

    Time frame: Day 1 (BL) Week 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12 Week 25 Year 1

  5. Working Alliance Inventory for Internet Interventions (WAI-I; Gómez Penedo et al., 2020).

    12-items self-report questionnaire with 5 Likert response options. Assesses working alliance in internet-based interventions. Validated in German sample of adults with depressive symptoms receiving guided online intervention

    Time frame: Week 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12

  6. Emotional Processing Self Report (EP-SR; Fisher et al., 2025)

    Self-report 7-items questionnaire with 5 Likert response options. Assesses emotional processing during therapeutic sessions in three independent dimensions: emotional expression, regulation and understanding emotional meaning. The instrument demonstrates adequate psychometrics properties, with internal consistency, convergent, incremental and predictive validity in clinical sample. It has not yet been validated in Spanish speaking population.

    Time frame: Week 3, 6, 9, 12 Week 25 Year 1

  7. Unified Protocol Skill Use Scale (UPSUS; Southward, & Sauer-Zavala, 2022)

    Self-report 7-items questionnaire with 7 Likert response options. Assesses the use of emotional regulation skills from Barlow's Unified Protocol (UP). Adapted for Spanish speaking population

    Time frame: Week 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12

  8. Brief Positive and Negative Affect Schedule (Brief PANAS; Watson et al., 1988

    Self-report 10-items questionnaire with 5 Likert response options (1 to 5). Assesses positive and negative affectivity (trait/state) during the past few weeks. Adapted for Spanish speaking population

    Time frame: Day 1 (BL) Week 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12

  9. Quality of Life Index Spanish (QLI-Sp; Mezzich et al., 2000)

    Self-report questionnaire containing 10 ítems with 10 Likert response options. Assess physical and emotional wellbeing, social support, interpersonal functioning, personal satisfaction and overall assessment of quality of life. Validated in Spanish speaking population with adequate psychometric properties in clinical sample (α = .87).

    Time frame: Day 1 (BL) Week 3, 6, 9, 12 Week 25 Year 1

  10. Generalized Self-Efficacy Scale (GSES; Jerusalem & Schwarzer, 1992).

    Self-report 10-items questionnaire with 4-point Likert scale. Assesses general sense of perceived self-efficacy. Validated in Spanish speaking population with sound psychometric properties

    Time frame: Day 1 (BL) Week 3, 6, 9, 12 Week 25 Year 1

Other outcomes

  1. Personality Inventory for DSM-5 (PID-5; Krueger et al., 2012).

    Self-report 31-items questionnaire with 5-point Likert scale which assesses maladaptive personality traits proposed in the DSM-5. Validated in Spanish speaking population with adequate psychometric properties

    Time frame: Day 1 (BL) Week 3, 12

  2. Level of Personal Functioning Scale - Brief Form 2.0 (LPFS-BF 2.0; Weekers et al., 2019).

    Self-report 12-items questionnaire with 4-point Likert response options. Asseses levels of personality functioning according to the alternative model of personality disorders of DSM-5. There is Spanish version available

    Time frame: Day 1 (BL) Week 3, 12

  3. Credibility/Expectancy Questionnaire (CEQ; Devilly & Borkovec, 2000).

    Self-report questionnaire with Likert scale responses from 0 to 100%. Assesses treatment outcome expectations (patient subscale). High internal consistency (α =.79 -.90). Test-retest reliability: r = .82 for expectancy, r = .75 for credibility. Used in Spanish clinical trials with good results

    Time frame: Day 1 (BL) Week 3, 6, 9, 12 Week 25 Year 1

  4. System Usability Scale (SUS; Brooke, 1996).

    Self-report 10-items questionnaire with 5-point Likert scale (1 to 5). Good psychometric properties (α = .91, Lewis, 2018). Validated in Spain with adequate psychometric properties (Castilla et al., 2023). Assesses usability of a digital program or tool.

    Time frame: Week 3

07

Study locations

No study locations are listed for this record.

08

References and documents

09

Timeline

Tracking since Sep 25, 2026
ElapsedEstimatedEstimated, not yet reachedSimilar studies: half by the dot; the band is the middle halfHalf of similar studies reached it by the dot; the band is the middle half, from a quarter to three quarters

Start is estimated for May 2027; primary completion for Dec 2029, 31 months later.

Of 261 non-industry interventional studies with no phase under Depressive Disorder, half reached primary completion within 29 months of starting (the median), counting those still running; a quarter within 15 and three quarters within 45. This study's planned 31 months is close to that.

Counting every sponsor, half of 276 studies reached it within 29 months; a quarter within 15 and three quarters within 45.

How these figures are worked out, and which studies are left out of them.

Registered
May 26, 2025
First posted
Jul 3, 2025
StartEst.
May 1, 2027
Primary completionEst.
Dec 2029
CompletionEst.
Jul 2030
Last update
May 27, 2026
What these dates mean
Start.
When the first participant enrolled; while estimated, when the study expects to open to recruitment.
Primary completion.
When the last participant was examined or treated to collect data for the study's main question, its primary outcome. A study that stopped early gives the date its data collection stopped.
Completion.
When the last participant's last visit took place, for every outcome, secondary ones and side effects included: the end of the study. Often later than primary completion, sometimes the same day.
Actual and Est.
Actual means the registry says the date has happened. Est. (estimated) is a date the sponsor plans or expects. It can still move, and the sponsor is expected to change it to actual once it has passed.
No changes since tracking began. The registry record was last updated on May 27, 2026, before this site started recording changes on Sep 25, 2026. Its history is on ClinicalTrials.gov ↗
10

Registry details

Key details

Study ID
NCT07051148
Lead sponsor
Universitat Jaume I
Responsible party
Sponsor
First posted
Jul 3, 2025
Start date
May 1, 2027 (estimated)
Primary completion
Dec 2029 (estimated)
Completion
Jul 2030 (estimated)
Last update
May 27, 2026

Study contacts

Fernanda Longo Elia, Psychologist
Contact
FERLONGO1@GMAIL.COM
+541159643668

Oversight

Data monitoring committee
No
FDA-regulated drug
No
FDA-regulated device
No
View the source record on ClinicalTrials.gov ↗

Not currently enrolling

This study is not yet recruiting, as verified in May 2026. You cannot join it, but the record below documents what was studied.

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion